Sistasis Family Practice,inc. | |
147 E Academy St Asheboro NC 27203-5706 | |
(336) 633-1212 | |
(336) 633-1218 |
Full Name | Sistasis Family Practice,inc. |
---|---|
Speciality | Clinic/Center |
Location | 147 E Academy St, Asheboro, North Carolina |
Authorized Official Name and Position | Rowena Sistasis (VICE PRESIDENT) |
Authorized Official Contact | 3366331212 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Sistasis Family Practice,inc. Po Box 4247 Asheboro NC 27204-4247 Ph: (336) 633-1212 | Sistasis Family Practice,inc. 147 E Academy St Asheboro NC 27203-5706 Ph: (336) 633-1212 |
NPI Number | 1780645812 |
---|---|
Provider Enumeration Date | 03/29/2006 |
Last Update Date | 08/05/2010 |
Medicare PECOS PAC ID | 7719946243 |
---|---|
Medicare Enrollment ID | O20041008000770 |
News Archive
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
Even for poor villagers in rural Indonesia, information is power. That is the implication of a newly published study co-authored by MIT economists, which finds that recipients of government aid collect more of the goods intended for them when they know more about the aid program they're enrolled in.
Magnetic resonance imaging (MRI) enables radiologists to accurately identify tumors missed by mammography and ultrasound, according to a multicenter study comparing the three screening methods in women at high-risk for breast cancer.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1780645812 | NPI | - | NPPES |
89016FU | Medicaid | NC | |
016FU | Other | NC | BCBS GROUP NO. |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
Provider Name | Rowena Maria Sistasis |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1013990506 PECOS PAC ID: 9436118965 Enrollment ID: I20041012000788 |
News Archive
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
Even for poor villagers in rural Indonesia, information is power. That is the implication of a newly published study co-authored by MIT economists, which finds that recipients of government aid collect more of the goods intended for them when they know more about the aid program they're enrolled in.
Magnetic resonance imaging (MRI) enables radiologists to accurately identify tumors missed by mammography and ultrasound, according to a multicenter study comparing the three screening methods in women at high-risk for breast cancer.
› Verified 3 days ago
Provider Name | Jim Sistasis |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1629051115 PECOS PAC ID: 2163481698 Enrollment ID: I20041012000828 |
News Archive
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
Even for poor villagers in rural Indonesia, information is power. That is the implication of a newly published study co-authored by MIT economists, which finds that recipients of government aid collect more of the goods intended for them when they know more about the aid program they're enrolled in.
Magnetic resonance imaging (MRI) enables radiologists to accurately identify tumors missed by mammography and ultrasound, according to a multicenter study comparing the three screening methods in women at high-risk for breast cancer.
› Verified 3 days ago
News Archive
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
Even for poor villagers in rural Indonesia, information is power. That is the implication of a newly published study co-authored by MIT economists, which finds that recipients of government aid collect more of the goods intended for them when they know more about the aid program they're enrolled in.
Magnetic resonance imaging (MRI) enables radiologists to accurately identify tumors missed by mammography and ultrasound, according to a multicenter study comparing the three screening methods in women at high-risk for breast cancer.
› Verified 3 days ago
Gaston Family Health Services, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 207 Eagle Ln, Asheboro, NC 27205 Phone: 704-874-9005 | |
Randolph Health Gastroenterology Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 700 Sunset Ave, Asheboro, NC 27203 Phone: 336-625-0305 Fax: 336-625-9941 | |
Triad Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 Mack Rd Ste B, Asheboro, NC 27205 Phone: 336-510-0202 Fax: 336-493-4808 | |
Atrium Health Wake Forest Baptist Primary Care - Asheboro Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 223 W Ward St Ste. B, Asheboro, NC 27203 Phone: 336-702-1731 Fax: 336-636-5145 | |
White Oak Family Physicians, P.a. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 550 White Oak St, Asheboro, NC 27203 Phone: 336-625-1360 Fax: 336-625-1889 | |
Gaston Family Health Services, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5326 Us Highway 220 Bus S, Asheboro, NC 27205 Phone: 704-874-9005 | |
Gaston Family Health Services, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1831 N Fayetteville St, Asheboro, NC 27203 Phone: 336-672-1300 |